Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Graham G Russell

Bone

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Bone|May 11, 2011
Bisphosphonates: the first 40 yearsR Graham G Russell
Bone|April 5, 2023
Introduction to the Bisphosphonate Special IssueRichard Eastell, R Graham G Russell
Bone|December 30, 2011
From nuclear physics to bone cell biology--Maureen Owen--1927-2011James T Triffitt, R Graham G Russell
Bone|December 15, 2010
Denosumab and bisphosphonates: different mechanisms of action and effectsRoland Baron, Serge Ferrari, R Graham G Russell
Bone|May 22, 2020
History of alendronateSteven R Cummings, Arthur C Santora, Dennis M Black, et al.
Bone|April 19, 2011
Risedronate does not reduce mechanical loading-related increases in cortical and trabecular bone mass in miceToshihiro Sugiyama, Lee B Meakin, Gabriel L Galea, et al.
Bone|March 24, 2021
Bisphosphonates in dentistry: Historical perspectives, adverse effects, and novel applicationsParish P Sedghizadeh, Shuting Sun, Allan C Jones, et al.
Bone|May 1, 2020
ZoledronateIan R Reid, Jonathan R Green, Kenneth W Lyles, et al.
Bone|December 13, 2021
Bisphosphonates: The role of chemistry in understanding their biological actions and structure-activity relationships, and new directions for their therapeutic useFrank H Ebetino, Shuting Sun, Philip Cherian, et al.
Bone|August 31, 2015
The inhibition of human farnesyl pyrophosphate synthase by nitrogen-containing bisphosphonates. Elucidating the role of active site threonine 201 and tyrosine 204 residues using enzyme mutantsMaria K Tsoumpra, Joao R Muniz, Bobby L Barnett, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Bone|May 11, 2011
Bisphosphonates: the first 40 yearsR Graham G Russell
Bone|April 5, 2023
Introduction to the Bisphosphonate Special IssueRichard Eastell, R Graham G Russell
Bone|December 30, 2011
From nuclear physics to bone cell biology--Maureen Owen--1927-2011James T Triffitt, R Graham G Russell
Bone|December 15, 2010
Denosumab and bisphosphonates: different mechanisms of action and effectsRoland Baron, Serge Ferrari, R Graham G Russell
Bone|May 22, 2020
History of alendronateSteven R Cummings, Arthur C Santora, Dennis M Black, et al.
Bone|April 19, 2011
Risedronate does not reduce mechanical loading-related increases in cortical and trabecular bone mass in miceToshihiro Sugiyama, Lee B Meakin, Gabriel L Galea, et al.
Bone|March 24, 2021
Bisphosphonates in dentistry: Historical perspectives, adverse effects, and novel applicationsParish P Sedghizadeh, Shuting Sun, Allan C Jones, et al.
Bone|May 1, 2020
ZoledronateIan R Reid, Jonathan R Green, Kenneth W Lyles, et al.
Bone|December 13, 2021
Bisphosphonates: The role of chemistry in understanding their biological actions and structure-activity relationships, and new directions for their therapeutic useFrank H Ebetino, Shuting Sun, Philip Cherian, et al.
Bone|August 31, 2015
The inhibition of human farnesyl pyrophosphate synthase by nitrogen-containing bisphosphonates. Elucidating the role of active site threonine 201 and tyrosine 204 residues using enzyme mutantsMaria K Tsoumpra, Joao R Muniz, Bobby L Barnett, et al.
Pageof 2